Cagrilintide 5mg

Product Summary:
Cagrilintide is a novel, long-acting acylated amylin analogue under investigation for its potential roles in metabolic regulation, appetite suppression, and energy balance. This research-grade compound is intended exclusively for scientific exploration and is not approved for human or veterinary use.

Key Features:

• High Purity: Manufactured to meet stringent purity standards, ensuring reliability in experimental applications.
• Extended Activity: Engineered for prolonged activity, facilitating studies requiring sustained amylin receptor engagement.
• Versatile Research Applications: Suitable for investigations into metabolic disorders, obesity, and related physiological processes.

Product Details:

Chemical Information:

• CAS Number: 1415456-99-3
• Molecular Formula: C194H312N54O59S2
• Molecular Weight: Approximately 4469.06 g/mol
• Synonyms: Long-acting amylin analogue, AMYR/CTR agonist

Physical Properties:

• Appearance: White to off-white solid
• Solubility: Soluble in water and aqueous buffers
• Purity: ≥98% (HPLC)

Packaging:

• Available in 1 mg, 5 mg, and 10 mg vials
• Sealed under inert gas to maintain stability

Applications:

• For Research Use Only: Designed exclusively for laboratory research, including in vitro and in vivo studies.
• Research Areas:
  • Metabolic regulation
  • Appetite control mechanisms
  • Energy homeostasis
  • Obesity and related metabolic disorders

Storage Instructions:

• Store at -20°C in a dry, tightly sealed container.
• Protect from light and moisture to maintain compound integrity.
• Adhere to institutional safety protocols for handling and disposal.

Regulatory and Patent Notice:

• Patent Disclaimer: Cagrilintide may be subject to patent protections in certain jurisdictions. Users are responsible for ensuring compliance with applicable intellectual property laws.
• Compliance Warning: This compound is not approved by the FDA or any other regulatory body for medical use. It is provided strictly for research purposes.

Safety Information:

• Warnings:
  • Not for human or veterinary consumption.
  • Not intended for diagnostic or therapeutic applications.
  • Improper use may result in legal and safety consequences.
• Safety Precautions:
  • Handle within a controlled laboratory environment by trained personnel.
  • Utilize appropriate personal protective equipment (PPE).
  • Consult the Safety Data Sheet (SDS) for comprehensive handling guidelines.

Disclaimer:
This product is sold strictly for lawful research purposes and must not be used beyond its intended scope. Purchasers are responsible for compliance with all relevant local, state, and federal regulations.

Frequently Asked Questions (FAQ):

Q: Can Cagrilintide be used in clinical trials?
A: No, this product is intended solely for preclinical research and is not approved for clinical use.

Q: Is there a recommended protocol for dissolving Cagrilintide?
A: It is recommended to dissolve Cagrilintide in sterile water or an appropriate aqueous buffer. Refer to your laboratory’s standard operating procedures for peptide reconstitution.

Q: Are there known interactions with other research compounds?
A: Studies have explored the combined use of Cagrilintide with other agents, such as semaglutide, in research settings. However, users should conduct thorough literature reviews and risk assessments before combining compounds in experimental designs.

References:

• ChemicalBook. (2024). Cagrilintide | 1415456-99-3. Retrieved from
  Chemical Book
• Peptides.org. (2024). Cagrilintide | Benefits and Research Applications. Retrieved from
  Peptides
• MedChemExpress. (2024). Cagrilintide | AMYR/CTR agonist. Retrieved from
  MedChemExpress
• Peptide Sciences. (2024). Cagrilintide Research: What is Cagrilintide? How does it work? Retrieved from
  Peptide Sciences
• Wikipedia. (2024). Cagrilintide. Retrieved from
  Wikipedia